EGFR and hypertensive nephropathy: Several key signaling effectors including RAAS peptides may be involved (Sun, 2019), but recent evidence implicates EGFR as a key player in the pathology of hypertensive nephropathy (Benter et al., 2009a; Tang et al., 2013b; Staruschenko et al., 2013) ((for a summary of selected studies see also Table 3)).